References and Notes
<A NAME="RD11706ST-1">1</A>
Koehn FE.
Longley RE.
Reed JK.
J. Nat. Prod.
1992,
55:
613
<A NAME="RD11706ST-2">2</A>
Pettit GR.
Kamano Y.
Dufresne C.
Cerny RL.
Herald CL.
Schmidt JM.
J. Org. Chem.
1989,
54:
6005
<A NAME="RD11706ST-3">3</A>
Nakamura H.
Iitaka Y.
Sakakibara H.
Umezawa H.
J. Antibiot.
1974,
27:
894
<A NAME="RD11706ST-4">4</A>
Nagle DG.
Paul VJ.
Roberts MA.
Tetrahedron Lett.
1996,
37:
6263
<A NAME="RD11706ST-5">5</A>
Hargreaves MK.
Pritchard JG.
Dave HR.
Chem. Rev.
1970,
70:
439
<A NAME="RD11706ST-6A">6a</A>
Davidson D.
Skovronek H.
J. Am. Chem. Soc.
1958,
80:
376
<A NAME="RD11706ST-6B">6b</A>
Zil’berman EN.
Russ. Chem. Rev.
1960,
29:
331
<A NAME="RD11706ST-6C">6c</A>
Durrell WS.
Young JA.
Dresdner RD.
J. Org. Chem.
1963,
28:
831
<A NAME="RD11706ST-6D">6d</A>
Bowser JR.
Williams PJ.
Kurz K.
J. Org. Chem.
1983,
48:
4111
<A NAME="RD11706ST-7A">7a</A>
Wheeler OH.
Rosado O. In
The Chemistry of Amides
Zabicky J.
J. Wiley and Sons;
New York:
1970.
p.335
<A NAME="RD11706ST-7B">7b</A>
Challis BC.
Challis J. In
The Chemistry of Amides
Zabicky J.
J. Wiley and Sons;
New York:
1970.
p.759
<A NAME="RD11706ST-8">8</A>
Schnyder A.
Indolese AF.
J. Org. Chem.
2002,
67:
594
<A NAME="RD11706ST-9">9</A>
Bates RB.
Fletcher FA.
Janda KD.
Miller WA.
J. Org. Chem.
1984,
49:
3038
<A NAME="RD11706ST-10">10</A>
Tanaka KI.
Yoshifuji S.
Nitta Y.
Chem. Pharm. Bull.
1987,
35:
364
<A NAME="RD11706ST-11">11</A>
Andrus MB.
Li W.
Keyes RF.
Tetrahedron Lett.
1998,
39:
5465
<A NAME="RD11706ST-12">12</A>
Lin YI.
Lang SA.
Synthesis
1980,
119
<A NAME="RD11706ST-13">13</A>
Kantlehner W.
Fischer P.
Kugel W.
Moehring E.
Bredereck H.
Justus Liebigs Ann. Chem.
1978,
512
<A NAME="RD11706ST-14">14</A>
Atanasov I.
Petrov I.
Ognyanova V.
Mollov N.
Synth. Commun.
1990,
20:
2083
<A NAME="RD11706ST-15">15</A>
Yamamoto Y.
Onishi S.
Azuma Y.
Synthesis
1981,
122
<A NAME="RD11706ST-16">16</A>
Seiller B.
Heins D.
Bruneau C.
Dixneuf PH.
Tetrahedron
1995,
51:
10901
<A NAME="RD11706ST-17A">17a</A>
Zolfigol MA.
Tetrahedron
2001,
57:
9509
<A NAME="RD11706ST-17B">17b</A>
Salehi P.
Dabiri M.
Zolfigol MA.
Bodaghifard MA.
Tetrahedron Lett.
2003,
44:
2889
<A NAME="RD11706ST-17C">17c</A>
Zolfigol MA.
Shirini F.
Ghorbani Choghamarani A.
Mohammadpoor Baltork I.
Green Chem.
2002,
4:
562
<A NAME="RD11706ST-17D">17d</A>
Salehi P.
Dabiri M.
Zolfigol MA.
Bodaghi Fard MA.
J. Braz. Chem. Soc.
2004,
15:
773
<A NAME="RD11706ST-17E">17e</A>
Salehi P.
Dabiri M.
Zolfigol MA.
Bodaghi Fard MA.
Heterocycles
2003,
60:
2435
<A NAME="RD11706ST-17F">17f</A>
Salehi P.
Dabiri M.
Zolfigol MA.
Baghbanzadeh M.
Tetrahedron Lett.
2005,
46:
7051
<A NAME="RD11706ST-17G">17g</A>
Salehi P.
Zolfigol MA.
Shirini F.
Baghbanzadeh M.
Curr. Org. Chem.
2006,
10:
2171
<A NAME="RD11706ST-18A">18a</A>
Benson FR.
Ritter JJ.
J. Am. Chem. Soc.
1949,
71:
4128
<A NAME="RD11706ST-18B">18b</A>
Salehi P.
Khodaei MM.
Keyvan A.
Synth. Commun.
2001,
31:
1947 ; and other references cited therein
<A NAME="RD11706ST-19">19</A>
General Procedure for Liquid Nitriles
A mixture of 50 mmol of nitrile, silica sulfuric acid (0.18 g, equal to 1.36 mmol
H+) and 1 mmol of carboxylic anhydride was heated in a 25 mL round-bottomed flask at
60-70 °C. The reactions were completed within 6-8 h as monitored by TLC (eluent, EtOAc-PE,
1:1). The mixture was filtered and solvent was evaporated under reduced pressure.
A solution of NaHCO3 in H2O (1%, 10 mL) was added and the mixture was extracted with Et2O (3 × 25 mL). The organic layer was separated and dried over Na2SO4. When necessary, the crude product was purified by preparative TLC on silica gel.
General Procedure for Solid Nitriles
In a round-bottomed flask the solid nitrile (1 mmol), car-boxylic anhydride (1 mmol)
and silica sulfuric acid (0.18 g, equal to 1.36 mmol H+) were mixed thoroughly. The flask was heated at 40-50 °C with concomitant stirring.
After completion of the reaction confirmed by TLC (eluent: EtOAc-PE, 1:9), EtOAc (15
mL) was added and filtered. The filtrate was concentrated and purified by preparative
TLC.
<A NAME="RD11706ST-20">20</A>
Spectroscopic Data for Entries 1-16
N-Acetylacetamide (entry 1): white solid, mp 73-74 °C. 1H NMR (300 MHz, CDCl3): δ = 2.07 (s, 6 H), 8.72 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 24.91, 171.96. IR (KBr): 3410, 3265, 3215, 1732 cm-1. MS (EI): m/z (rel. intensity) = 101 (10) [M+], 72 (35), 58 (100).
N-Pentanoylacetamide (entry 2): white solid, mp 62-64 °C. 1H NMR (300 MHz, CDCl3): δ = 0.94 (t, J = 7.3 Hz, 3 H), 1.33-1.45 (m, 2 H), 1.60-1.70 (m, 2 H), 2.38 (s, 3 H), 2.52 (t, J = 7.4 Hz, 2 H), 8.57 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.75, 22.17, 25.12, 26.45, 37.03, 172.41, 174.03. IR (KBr): 3260, 3230, 1729
cm-1. MS (EI): m/z (rel. intensity) = 144 (41) [M+], 114 (25), 101 (58), 59 (82), 43 (100).
N-Acetylpropionamide (entry 3): white solid, mp 85-86 °C. 1H NMR (300 MHz, CDCl3): δ = 0.93 (t, J = 7.4 Hz, 3 H), 2.11 (s, 3 H), 2.32 (q, J = 7.4 Hz, 2 H), 8.25 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 8.37, 25.10, 29.69, 30.63, 172.20, 174.63. IR (KBr): 3265, 3236, 1727 cm-1. MS (EI): m/z (rel. intensity) = 115 (50) [M+], 97 (25), 71 (81), 57 (100). Anal. Calcd for C5H9NO2: C, 52.16; H, 7.88; N, 12.17; O, 27.79. Found: C, 52.08; H, 7.79; N, 12.09; O, 27.74.
N-Butyrylpropionamide (entry 4): white solid, mp 109-110 °C. 1H NMR (300 MHz, CDCl3): δ = 0.99 (t, J = 7.4 Hz, 3 H), 1.17 (t, J = 7.4 Hz, 3 H), 1.65-1.73 (m, 2 H), 2.58 (t, J = 7.2 Hz, 2 H), 2.66 (q, J = 7.1 Hz, 2 H), 8.84 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 8.35, 13.62, 17.86, 30.76, 39.27, 174.18, 175.21. IR (KBr): 3260, 3227, 1731
cm-1. MS (EI): m/z (rel. intensity) = 144 (12) [M+], 115 (25), 87 (28), 74 (80), 57 (100).
N-Butyrylisobutyramide (entry 5): white solid, mp 108-109 °C. 1H NMR (300 MHz, CDCl3): δ = 0.72 (t, J = 7.4 Hz, 3 H), 0.95 (d, J = 6.9 Hz, 6 H), 1.37-1.48 (m, 2 H), 2.45 (t, J = 7.4 Hz, 2 H), 2.49-2.56 (m, 1 H), 7.90 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.63, 17.72, 18.80, 35.86, 39.32, 175.64, 177.57. IR (KBr): 3260, 3234, 1727
cm-1. MS (EI): m/z (rel. intensity) = 157 (40) [M+], 88 (62), 71(100), 43 (81).
N-Acetyl-2-chloroacetamide (entry 6): white solid, mp 114-115 °C. 1H NMR (300 MHz, CDCl3): δ = 2.43 (s, 3 H), 4.28 (s, 2 H), 8.67 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 24.91, 43.66, 166.83, 171.31. IR (KBr): 3260, 3245, 1740 cm-1. MS (EI): m/z (rel. intensity) = 137 (11) [M + 2], 135 (34) [M+], 93 (20), 43(100).
N-Butyryl-2-chloroacetamide (entry 7): white solid, mp 111-112 °C. 1H NMR (300 MHz, CDCl3): δ = 1.00 (t, J = 7.4 Hz, 3 H), 1.70 (m, 2 H), 2.64 (t, J = 7.3 Hz, 2 H), 4.35 (s, 2 H), 8.51 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.54, 17.67, 39.05, 44.11, 167.30, 173.75. IR (KBr): 3255, 3242, 1740 cm-1. MS (EI): m/z (rel. intensity) = 165 (5) [M + 2], 163 (16) [M+], 135 (77), 114 (35), 71 (100), 43 (80).
N-Pentanoyl-2-chloroacetamide (entry 8): white solid, mp 104-105 °C. 1H NMR (300 MHz, CDCl3): δ = 0.95 (t, J = 7.3 Hz, 3 H), 1.34-1.46 (m, 2 H), 1.61-1.71 (m, 2 H), 2.66 (t, J = 7.4 Hz, 2 H), 4.33 (s, 2 H), 8.53 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.76, 22.15, 26.22, 36.99, 44.01, 166.97, 173.76. IR (KBr): 3260, 3235, 1739
cm-1. MS (EI): m/z (rel. intensity) = 179 (3) [M + 2], 177 (10) [M+], 135 (30), 107(33), 85 (100), 57 (88). Anal. Calcd for C7H12ClNO2: C, 47.33; H, 6.81; Cl, 19.96; N, 7.89; O, 18.01. Found: C, 47.03; H, 6.77; N, 7.81;
O, 17.95.
N-Acetylbenzamide (entry 9): white solid, mp 112-114 °C. 1H NMR (300 MHz, CDCl3): δ = 2.39 (s, 3 H), 7.21-7.63 (m, 5 H), 8.44 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 25.47, 127.58, 129.08, 132.72, 133.30, 165.53, 173.15. IR (KBr): 3295, 1722
cm-1. MS (EI): m/z (rel. intensity) = 163 (10) [M+], 105 (100), 77 (78).
N-Acetyl-4-methylbenzamide (entry 10): white solid, mp 103-104 °C. 1H NMR (300 MHz, CDCl3): d = 2.45 (s, 3 H), 2.63 (s, 3 H), 7.32 (d, J = 8.0 Hz, 2 H), 7.75 (d, J = 8.2 Hz, 2 H), 8.59 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 21.59, 25.65, 127.93, 129.58, 129.80, 144.08, 165.84, 174.10. IR (KBr): 3395,
3285, 1709 cm-1. MS (EI): m/z (rel. inten-sity) = 177 (25) [M+], 162 (30), 119 (100), 91 (80), 65 (52). Anal. Calcd for C10H11NO2: C, 67.78; H, 6.26; N, 7.9; O, 18.06. Found: C, 67.62; H, 5.83; N, 8.00; O, 18.54.
N-Butyryl-4-methylbenzamide (entry 11): white solid, mp 87-88 °C. 1H NMR (300 MHz, CDCl3): δ = 1.04 (t, J = 7.3 Hz, 3 H), 1.73-1.82 (m, 2 H), 2.44 (s, 3 H), 7.31 (d, J = 8.0 Hz, 2 H), 7.76 (d, J = 8.0 Hz, 2 H), 8.64 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.74, 17.59, 21.59, 39.42, 127.69, 129.65, 130.00, 144.05, 165.37, 176.24.
IR (KBr): 3270, 2950, 2935, 1710 cm-1. MS (EI): m/z (rel. intensity) = 205(32) [M+], 136 (20), 119 (100), 91 (33). Anal. Calcd for C12H15NO2: C, 70.22; H, 7.37; N, 6.82; O, 15.59. Found: C, 69.95; H, 7.01; N, 6.79; O, 15.52.
N-Pentanoyl-4-methylbenzamide (entry 12): white solid, mp 101-102 °C. 1H NMR (300 MHz, CDCl3): δ = 0.97 (t, J = 7.3 Hz, 3 H), 1.38-1.48 (m, 2 H), 1.66-1.76 (m, 2 H), 2.44 (s, 3 H), 3.02 (t, J = 7.5 Hz, 2 H), 7.31 (d, J = 7.9 Hz, 2 H), 7.79 (d, J = 8.2 Hz, 2 H), 8.53 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.89, 21.59, 22.32, 26.27, 37.30, 127.73, 129.65, 130.04, 144.04, 165.40,
176.46. IR (KBr): 3280, 2920, 2924, 1699 cm-1. MS (EI): m/z (rel. intensity) = 219 (34) [M+], 136 (20), 119 (100), 91 (50).
N-Acetyl-4-nitrobenzamide (entry 13): white solid, mp 118 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3 H), 4.07 (s, 2 H), 7.47 (d, J = 8.5 Hz, 2 H), 8.1 (br s, 1 H), 8.23 (d, J = 8.6 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 25.08, 41.06, 124.00, 130.57, 140.63, 147.33, 170.66, 171.98. IR (KBr): 3435,
3250, 2990, 1732 cm-1. MS (EI): m/z (rel. intensity) = 222 (11) [M+], 163 (88), 137 (30), 43 (100). Anal. Calcd for C10H10N2O4: C, 54.05; H, 4.54; N, 12.61; O, 28.80. Found: C, 54.02; H, 4.50; N, 12.55; O, 28.77.
N-Butyryl-4-nitrobenzamide (entry 14): white solid, mp 122 °C. 1H NMR (300 MHz, CDCl3): δ = 0.99 (t, J = 7.4 Hz, 3 H), 1.64-1.74 (m, 2 H), 2.50 (t, J = 7.3 Hz, 2 H), 4.16 (s, 2 H) 7.47 (d, J = 8.8 Hz, 2 H), 8.09 (br s, 1 H), 8.22 (d, J = 8.8 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 13.56, 17.80, 39.30, 43.51, 123.74, 130.60, 140.87, 147.27, 171.25, 174.20.
IR (KBr): 3205, 3000, 1729 cm-1. MS (EI): m/z (rel. intensity) = 250 (10) [M+], 180 (30), 163 (50), 133 (25), 88 (50), 71 (100), 43 (75).
N-Acetyl-3-chlorobenzamide (entry 15): white solid, mp 105-107 °C. 1H NMR (300 MHz, CDCl3): δ = 2.63 (s, 3 H), 7.45-7.49 (m, 3 H), 7.88 (s, 1 H), 8.71 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 25.65, 125.75, 128.24, 130.23, 133.24, 134.41, 135.27, 164.63, 173.81. IR (KBr):
3418, 3196, 1718 cm-1. MS (EI): m/z (rel. intensity) = 199 (8) [M + 2], 197 (16) [M+], 168 (18), 139 (100), 111 (25), 75 (20), 71 (100), 43 (50).
N-Butyryl-3-chlorobenzamide (entry 16): white solid, mp 97-100 °C. 1H NMR (300 MHz, CDCl3): δ = 1.04 (t, J = 7.4 Hz, 3 H), 1.73-1.80 (m, 2 H), 2.98 (t, J = 7.4 Hz, 2 H), 7.44-7.73 (m, 3 H), 7.87 (s, 1 H), 8.54 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.71, 17.46, 39.58, 125.87, 128.22, 129.78, 130.16, 133.13, 133.50, 134.59,
135.20, 164.55, 176.88. IR (KBr): 3420, 3185, 2920, 1710 cm-1. MS (EI): m/z (rel. intensity) = 227 (2) [M + 2], 225 (7) [M+], 196 (30), 156 (75), 139 (100), 111 (75), 75 (50), 43 (88).